Posted On: 06/24/2013 9:32:32 AM
Post# of 5066
I'm sure all or mot of you saw or will see the post with the following exert,
"It would really be awesome if BMSN were able to successfully exit P2 clinical trial as their business model doesn't take the studies beyond P2. Upon successful completion of P2, they would divest HemaXellerate to a bigger pharma. "
On the note of still trying to learn how this works what happens to BMSN, their revenue, PPS, essentially everything if Hema were to be sold to another pharma?
"It would really be awesome if BMSN were able to successfully exit P2 clinical trial as their business model doesn't take the studies beyond P2. Upon successful completion of P2, they would divest HemaXellerate to a bigger pharma. "
On the note of still trying to learn how this works what happens to BMSN, their revenue, PPS, essentially everything if Hema were to be sold to another pharma?
(0)
(0)
